Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Topical finasteride is an effective and safer treatment for male hair loss.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

The new 5% minoxidil foam is as effective and safe as Rogaine® for treating hair loss in Chinese men.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Dutasteride is a safe and effective treatment for hair loss.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

PLD is an effective and safer alternative for treating breast cancer.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Korean hair is typically thicker with a slower growth rate, and treatments like Dutasteride are effective for male pattern hair loss without major side effects.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

KX-826 is safe and effectively increases hair count in men with hair loss.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Male hair loss is mainly due to thinner hair, not less hair.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.